Skip to main content
. 2017 Mar 23;12(3):e0174333. doi: 10.1371/journal.pone.0174333

Fig 2. Cumulative survival rates of diabetic and non-diabetic patients among different BCLC staging groups.

Fig 2

Differences in survival between diabetic and non-diabetic patients are significant in the whole cohort (p = 0.017, panel A), BCLC stage 0 and stage A (p< 0.001, panel B), and BCLC stage B (p = 0.012, panel C), but not in BCLC stage C and stage D (p = 0.132, panel D).